CHROMADEX CORP
CHROMADEX CORP
Action · US1710774076 · CDXC · A2AG5N (XNCM)
Aperçu Indicateurs financiers
9,51 USD
2,48 % 0,23 USD
NASDAQ CAPITAL MARKET (XNAS) · Cours et graphiques actuels sur MoneyPeak
25.07.2025 09:18

Cours actuels de CHROMADEX CORP

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
NAGE
USD
25.07.2025 09:18
9,51 USD
0,24 USD
+2,59 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
2,48 % -9,43 % -32,70 % 28,60 % 59,83 % 197,19 % 84,30 %

Profil de l'entreprise pour CHROMADEX CORP Action

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Données de l'entreprise

Nom CHROMADEX CORP
Société ChromaDex Corporation
Symbole CDXC
Site web https://www.chromadex.com
Marché d'origine XNCM NASDAQ CAPITAL MARKET
WKN A2AG5N
ISIN US1710774076
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Frank Louis Jaksch Jr.
Capitalisation boursière 612 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 10900 Wilshire Boulevard, 90024 Los Angeles
Date d'introduction en bourse 2008-06-25

Fractionnements d'actions

Date Fractionnement
13.04.2016 1:3

Changements d'identifiant

Date De À
19.03.2025 CDXC NAGE

Symboles boursiers

Nom Symbole
Frankfurt OCD1.F
NASDAQ CDXC
NASDAQ NAGE

Autres actions

Les investisseurs qui détiennent CHROMADEX CORP ont également les actions suivantes dans leur portefeuille :
AMAZON.CO INC
AMAZON.CO INC Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
DEUTSCHE TELEKOM AG
DEUTSCHE TELEKOM AG Action
INTEL CORP
INTEL CORP Action
MEAG EUREST A
MEAG EUREST A Fonds
MICROSOFT CORP
MICROSOFT CORP Action
POTBELLY CORP
POTBELLY CORP Action
QUALCOMM INC
QUALCOMM INC Action
ROCKWELL AU. 2028
ROCKWELL AU. 2028 Obligation
Vanguard Long-Term Tax-Exempt Fund
Vanguard Long-Term Tax-Exempt Fund Fonds
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025